Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
Nov 20, 2026, 11:28

Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients

Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared Guillaume Lettre’s post on LinkedIn:

“Precision medicine is making its entry into sickle cell disease (sickle cell disease).

Patients with this chronically underfunded and little-known disease deserve the same genomic and proteomic tools.

Thank you Guillaume Lettre, Pr Pablo Bartolucci, Cristian Groza for this great advance!”

Guillaume Lettre, Professor of Medicine at University of Montreal, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in PLoS Genetics, adding:

“Sickle cell disease affects more than 7 million people worldwide.

It is the most common monogenic disease in the world, yet it remains chronically neglected and underfunded, and patients still have very few therapeutic options.

We believe these patients deserve the same cutting-edge genomic tools that are now routinely applied to diseases more common in wealthier populations.

That is the spirit of our new paper, out now in PLoS Genetics.

We measured more than 5,000 plasma proteins in sickle cell disease patients and mapped the genetic variants that regulate their levels (pQTLs).

This is, to our knowledge, one of the first large-scale proteogenomic resources built specifically in this population.

We also used these results to prioritize circulating proteins that may influence fetal hemoglobin, the major protective factor in sickle cell disease and a key therapeutic target.

Congratulations to Cristian Groza, who led this work, and to all our collaborators, including Pablo Bartolucci and the team in Créteil.

Above all, thank you to the patients who made this research possible.

And Canadian Institutes of Health Research for the funding.

There is much more to do, and we hope this resource will help others bring modern genomics to sickle cell disease.”

Title: Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients

Authors: Cristian Groza, Arnaud Chignon, Ken Sin Lo, Vanessa Bellegarde, Pablo Bartolucci, Guillaume Lettre

Stéphanie Forté

Stay updated on all scientific advances with Hemostasis Today.